T24 In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-1022-YF3252
Target Cell Organism: Human
Target Cell Name: T24
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide T24-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
T24
Target Cell Organism
Human
Target Cell Background
The T24 cell line was established from a transitional cell carcinoma of the bladder in a female patient in 1973. Reports in the literature indicated a wide range of tumorigenicity for T24 when injected subcutaneously in immunocompromised murine hosts.
Related Diseases
Bladder Cancer
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Short Description
T24-cell based In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry